Eisai Co., Ltd. (EII.F) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close27.68

Open29.32

Day range—

52-week range19.7129.94

Off day high0.00%

Off 52-week high−2.07%

Volume100

Avg. volume (3M)107

Market cap8.28B

EPS (TTM)0.7800

Forward P/E24.85

P/E ratio (TTM)37.59

Dividend yield3.23% (0.9100)

Beta (5Y)-0.15

Shares outstanding282.24M

Short interest—

Earnings dateNov 10, 2026

Analyst target—

Profit margin4.94%

Against its peers

Compare in full ›

	EII.F	300558.SZ	SH0.F	ECILC.IS	6998.HK	4547.T
Market cap	8.28B	20.76B	14.58B	33.62B	3.11B	161.53B
P/E (TTM)	37.6	77.9	11.1	—	9.9	14.4
Forward P/E	24.8	29.2	5.5	—	-1.9	17.6
Price/book	1.6	3.2	1.5	0.6	0.7	0.7
Dividend yield	3.23%	0.31%	3.17%	3.64%	—	3.46%
1-year change	+15.43%	−12.57%	+29.57%	−48.86%	−45.69%	−6.36%
Today	+5.92%	+1.62%	−4.89%	+2.04%	+0.32%	+3.06%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Eisai's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Betta Pharmaceuticals Co., Ltd.300558.SZ · Drug Manufacturers - Specialty & Generic	20.76B	49.05	+1.62%
Shionogi & Co., Ltd.SH0.F · Drug Manufacturers - Specialty & Generic	14.58B	17.13	−4.89%
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.ECILC.IS · Drug Manufacturers - Specialty & Generic	33.62B	49.06	+2.04%
Edding Genor Group Holdings Limited6998.HK · Drug Manufacturers - Specialty & Generic	3.11B	1.580	+0.32%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
Luye Pharma Group Ltd.LUP.F · Drug Manufacturers - Specialty & Generic	762.19M	0.1880	+3.87%
Neurocrine Biosciences, Inc.N1BI34.SA · Drug Manufacturers - Specialty & Generic	93.02B	45.95	−0.02%
Eris Lifesciences LimitedERIS.NS · Drug Manufacturers - Specialty & Generic	170.63B	1,229.90	+1.23%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Wedge Industrial Co.,Ltd.000534.SZ · Shantou, China	8.89B	17.45	+1.63%
Shandong Xinhua Pharmaceutical Company Limited000756.SZ · Zibo, China	8.88B	12.75	+0.55%
Anuh Pharma LimitedANUHPHR.BO · Mumbai, India	8.33B	83.13	+0.29%
Themis Medicare LimitedTHEMISMED.NS · Mumbai, India	9.44B	101.64	+2.13%
Shree Ganesh Remedies LimitedSGRL.BO · Ankleshwar, India	8.13B	633.40	−2.38%
North China Pharmaceutical Company.Ltd600812.SS · Shijiazhuang, China	8.34B	4.8600	+2.32%
Zhejiang Xianju Pharmaceutical Co., Ltd.002332.SZ · Xianju, China	8.91B	9.01	+0.11%
Shenzhen Chipscreen Biosciences Co., Ltd.688321.SS · Shenzhen, China	9.47B	21.39	+2.84%

Healthcare companies of a similar market value (7.92B).

Company	Mkt cap	Price	Today
TG Therapeutics, Inc.NKB2.F · Biotechnology	8.30B	54.20	−2.52%
Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S.TNZTP.IS · Medical Care Facilities	9.47B	23.68	+4.32%
Wedge Industrial Co.,Ltd.000534.SZ · Drug Manufacturers - Specialty & Generic	8.89B	17.45	+1.63%
Henry Schein, Inc.HS2.F · Medical Distribution	8.57B	77.50	+6.90%
Shanghai INT Medical Instruments Co., Ltd.1501.HK · Medical Instruments & Supplies	8.38B	29.800	+0.88%
Arrowhead Pharmaceuticals, Inc.ARWR · Biotechnology	8.71B	61.65	+3.56%
Teladoc Health, Inc.T2DH34.SA · Health Information Services	9.67B	53.05	+10.59%
HealthEquity, Inc.HQY · Health Information Services	9.00B	108.84	+6.67%

Also based in Tokyo, Japan, then elsewhere in Japan.

Company	Mkt cap	Price	Today
Honda Motor Co., Ltd.HMC.BA · Tokyo, Japan	230.66T	59,250.00	+4.13%
Recruit Holdings Co., Ltd.6098.T · Tokyo, Japan	25.01T	18,010.00	+2.62%
SoftBank Group Corp.9984.T · Tokyo, Japan	22.68T	3,980.00	−6.77%
Sumitomo Mitsui Financial Group, Inc.8316.T · Tokyo, Japan	24.02T	3,191.00	+1.43%
Sony Group Corporation6758.T · Tokyo, Japan	24.59T	4,211.00	+7.07%
Hitachi, Ltd.6501.T · Tokyo, Japan	21.27T	4,772.00	−2.49%
Tokyo Electron Limited8035.T · Tokyo, Japan	19.81T	8,753.00	−9.42%
Mitsubishi Corporation8058.T · Tokyo, Japan	19.32T	5,274.00	+2.45%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All EII.F news ›

BioSpace·6d agoPositive

Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference

TOKYO, Oct. 29, 2026 /PRNewswire/ -- Eisai Co., Ltd. announced today that it will present new Alzheimer's disease (AD) research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference, taking place November 16-19, 2026, in…

MCI BIIB GOOGL TLSA

Eisai Newsroom·Oct 26Negative

Eisai Presents Endometrial Cancer Patient Survey Data at SGO 2026 | Eisai US

70% of patients surveyed reported the burden of chemotherapy treatment was almost as great as the burden of the disease itself, and 71% would prefer not to receive it again Findings indicate that patients desire more discussion about…

MRK

TradingView·Oct 16Positive

Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026

TradingView Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026 TOKYO, Oct 16, 2026 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the presentation of clinical research acr

PFE AZN

MarketScreener·Oct 7Positive

Eisai and Biogen Receive Approval for LEQEMBI Pen Subcutaneous Formulation for Early Alzheimer?s Disease in Japan

Eisai Co., Ltd. and Biogen Inc. announced that LEQEMBI Pen, the subcutaneous formulation of the anti-amyloid beta protofibril antibody LEQEMBI has been approved in Japan as a new route of...

MCI LLY LH DGX

MarketScreener·Oct 7Positive

Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi

China's National Medical Products Administration approved Eisai and Biogen's subcutaneous autoinjector version of anti-amyloid beta protofibril antibody Leqembi as an initiation treatment for... Eisai, Biogen Secure China's Nod for…

MCI LLY NVO GOOGL

From the 4Search news index, newest first.